News & Articles
Selected Filters:
Urinary NMR diagnostics for inborn errors of metabolism using rule-based interpretation (for research use only)
Watch this on-demand webinar to learn about the potential of computer-assisted interpretation and linking disease markers identified by NMR to the metagene database
PerkinElmer SARS-CoV-2 RT-PCR assay receives FDA EUA for asymptomatic testing
Gold-standard testing of individuals without COVID-19 symptoms key to controlling the spread
Euroimmun launches SARS-CoV-2 test system to detect T-cell response
Novel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progression
Don't miss out on these 4 upcoming webinars
Explore topics from single-cell RNA sequencing sample preparation and precise weighing processes to COVID-19 serology testing and pediatric diagnostics
The quest for precision medicine: Decoding cancer pathogenesis and overcoming drug resistance
Dr. Komal Kumar Javarappa shares insights from the multidisciplinary forefront of immuno-oncology, where translational biologists race against time to optimize new cancer therapies
Gene modulation in primary human immune cells: Successful strategies and applications for CRISPRko, RNAi and beyond
Watch this on-demand webinar to learn more about manipulating the genes within physiologically relevant human immune cells
SARS-CoV-2 serology testing in the setting of vaccination
Join us on Friday, January 22, to discover why serology testing is necessary to understand whether vaccination results in seroconversion
AstraZeneca’s COVID-19 vaccine authorized for emergency supply in the UK
Working with the UK government, first vaccinations are to begin early in the new year
Seegene’s COVID-19/FluA,B/RSV test with extraction-free feature now available in Europe
The real-time RT-PCR assay can simultaneously detect and differentiate 8 target genes, the first and only test to do so in the world
Mologic receives CE mark approval for professional-use COVID-19 rapid antigen test
Preliminary results show 92% sensitivity and 100% specificity, compared with RT-PCR
Beckman Coulter launches one of the first high-quality, high-throughput COVID-19 antigen test ideal for mass testing in the U.S.
The Access SARS-CoV-2 Antigen assay is offered to healthcare providers at $4, making reliable and frequent mass testing affordable
Abbott’s BinaxNOW COVID-19 rapid test receives FDA emergency use authorization
First at-home, virtually guided service to bring rapid, reliable and affordable testing into the home where the result is delivered in minutes
Dealing with unpredictability: Manufacturing COVID-19 lateral flow tests during the pandemic
An insider’s look into the bottlenecks and challenges associated with manufacturing and supply chain workflows within lateral flow diagnostics
Roche receives FDA authorization for semi-quantitative test to measure the level of SARS-CoV-2 antibodies
Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein
Roche launches laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients
The Elecsys SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of active SARS-CoV-2 infection
CAR T: Dual-targeted cell therapy to prevent relapsed multiple myeloma: Your questions answered
Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape
New clues point to a protective shield that could change harmless bacteria into killers
The research helps shed light on genes responsible for a shield-like capsule that could help protect some bacteria from our immune system, making them deadly
Investigating traditional and modern approaches to antimicrobial susceptibility testing
Explore ways to improve time to result in critical pathways such as sepsis
Pfizer/BioNTech’s COVID-19 vaccine gets a major endorsement from FDA committee
In a 17-4 vote, the FDA vaccine advisory committee recommended that Pfizer/BioNTech’s COVID-19 vaccine should be distributed to the U.S.























